Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.39 -2.97%
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.38), $0.85 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Ares closes Japan logistics fund at ¥612 billion hard cap
- RBC Capital Reiterates Outperform Rating on Arrowhead Pharma (ARWR)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
